Armodafinil in binge eating disorder: a randomized, placebo-controlled trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Clinical Psychopharmacology

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/YIC.0000000000000079PMID 26011779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.

  2015cited by this paper
• Current and emerging drug treatments for binge eating disorder

  2014cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

  2014cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys.

  2013cited by this paper
• Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

  2012cited by this paper
• R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

  2012cited by this paper
• Enhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder

  2011cited by this paper
• The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

  2011cited by this paper
• Armodafinil in the treatment of excessive sleepiness

  2010cited by this paper
• The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.

  2010cited by this paper
• Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.

  2010cited by this paper
• Psychological treatments of binge eating disorder.

  2010cited by this paper
• The biology of binge eating.

  2009influential reference
• The validity and clinical utility of binge eating disorder.

  2009cited by this paper
• Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial

  2009cited by this paper
• Armodafinil for the treatment of excessive sleepiness.

  2009cited by this paper
• Review and Meta‐analysis of Pharmacotherapy for Binge‐eating Disorder

  2008cited by this paper
• Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.

  2008cited by this paper
• High‐dose escitalopram in the treatment of binge‐eating disorder with obesity: a placebo‐controlled monotherapy trial

  2008cited by this paper
• Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

  2007cited by this paper
• Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

  2007cited by this paper
• The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

  2007cited by this paper
• Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.

  2006cited by this paper
• Applied Longitudinal Analysis

  2004cited by this paper
• Toward an understanding of health services use in women with binge eating disorder.

  2004cited by this paper
• Quality of life in patients with binge eating disorder

  2004cited by this paper
• Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

  2003cited by this paper
• A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

  2003cited by this paper
• Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

  2003cited by this paper
• A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

  2002cited by this paper
• Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

  2000cited by this paper
• The rapid assessment of fatigue severity in cancer patients

  1999cited by this paper
• Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.

  1998cited by this paper
• The Inventory of Depressive Symptomatology (IDS): psychometric properties

  1996influential reference
• Assessment of eating disorders: interview or self-report questionnaire?

  1994cited by this paper
• Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

  1993cited by this paper
• The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

  1989influential reference
• The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

  1989cited by this paper
• An inventory for measuring clinical anxiety: psychometric properties.

  1988influential reference
• The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

  1985cited by this paper
• Psychological Treatments

  1975cited by this paper
• Positron Emission Tomography Study Examining The opaminergic Activity of Armodafinil in Adults Using 11 C ] Altropane and [ 11 C ] Raclopride

  year unknowncited by this paper

• Considering the Impact and Treatment of Sleep and Sleep Disorders in Eating Disorder Interventions.

  2026cites this paper
• Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis

  2025cites this paper
• Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review

  2023cites this paper
• An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials

  2022cites this paper
• Management of eating disorders for people with higher weight: clinical practice guideline

  2022cites this paper
• What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials

  2022cites this paper
• Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.

  2021cites this paper
• Binge Eating Disorder: A 5-Year Retrospective Study on Experimental Drugs

  2021cites this paper
• Eating Disorders (Anorexia Nervosa and Bulimia Nervosa, Binge Eating Disorder)

  2021cites this paper
• Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

  2021influential citation
• Medication for Binge Eating

  2020cites this paper
• Binge Eating: A Transdiagnostic Psychopathology

  2020cites this paper
• Central nervous system stimulants and drugs that suppress appetite

  2020cites this paper
• Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials

  2020cites this paper
• Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder.

  2020cites this paper
• Investigational drugs for the treatment of binge eating disorder (BED): an update

  2019cites this paper
• Psychosocial Evaluation and Management of Weight Loss Surgery Patients

  2018cites this paper
• Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis

  2018cites this paper
• Binge-Eating Disorder in Adults

  2016cites this paper
• Overview of the treatment of binge eating disorder

  2015cites this paper
• Current and Emerging Directions in the Treatment of Eating Disorders

  2012cites this paper